|
1
|
Wei KR, Zheng RS, Zhang SW, Liang ZH, Ou
ZX and Chen WQ: Nasopharyngeal carcinoma incidence and mortality in
China in 2010. Chin J Cancer. 33:381–387. 2014.PubMed/NCBI
|
|
2
|
Adham M, Kurniawan AN, Muhtadi AI, Roezin
A, Hermani B, Gondhowiardjo S, Tan IB and Middeldorp JM:
Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence,
signs, and symptoms at presentation. Chin J Cancer. 31:185–196.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tao CJ, Liu X, Tang LL, Mao YP, Chen L, Li
WF, Yu XL, Liu LZ, Zhang R, Lin AH, et al: Long-term outcome and
late toxicities of simultaneous integrated boost-intensity
modulated radiotherapy in pediatric and adolescent nasopharyngeal
carcinoma. Chin J Cancer. 32:525–532. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liang FY, Sun W, Han P, Lu X, Lian YN and
Huang XM: Detecting plasma Epstein-Barr virus DNA to diagnose
postradiation nasopharyngeal skull base lesions in nasopharyngeal
carcinoma patients: a prospective study. Chin J Cancer. 31:142–149.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang WY, Twu CW, Lin WY, Jiang RS, Liang
KL, Chen KW, Wu CT, Shih YT and Lin JC: Plasma Epstein-Barr virus
DNA screening followed by 18F-fluoro-2-deoxy-D-glucose
positron emission tomography in detecting posttreatment failures of
nasopharyngeal carcinoma. Cancer. 117:4452–4459. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bar-Eli M: Role of interleukin-8 in tumor
growth and metastasis of human melanoma. Pathobiology. 67:12–18.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rofstad EK and Halsør EF: Vascular
endothelial growth factor, interleukin 8, platelet-derived
endothelial cell growth factor, and basic fibroblast growth factor
promote angiogenesis and metastasis in human melanoma xenografts.
Cancer Res. 60:4932–4938. 2000.PubMed/NCBI
|
|
8
|
Singh RK, Gutman M, Reich R and Bar-Eli M:
Ultraviolet B irradiation promotes tumorigenic and metastatic
properties in primary cutaneous melanoma via induction of
interleukin 8. Cancer Res. 55:3669–3674. 1995.PubMed/NCBI
|
|
9
|
Luca M, Huang S, Gershenwald JE, Singh RK,
Reich R and Bar-Eli M: Expression of interleukin-8 by human
melanoma cells up-regulates MMP-2 activity and increases tumor
growth and metastasis. Am J Pathol. 151:1105–1113. 1997.PubMed/NCBI
|
|
10
|
Inoue K, Slaton JW, Kim SJ, Perrotte P,
Eve BY, Bar-Eli M, Radinsky R and Dinney CP: Interleukin 8
expression regulates tumorigenicity and metastasis in human bladder
cancer. Cancer Res. 60:2290–2299. 2000.PubMed/NCBI
|
|
11
|
Shahzad MM, Arevalo JM, Armaiz-Pena GN, Lu
C, Stone RL, Moreno-Smith M, Nishimura M, Lee JW, Jennings NB,
Bottsford-Miller J, et al: Stress effects on FosB- and
interleukin-8 (IL8)-driven ovarian cancer growth and metastasis. J
Biol Chem. 285:35462–35470. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li XJ, Peng LX, Shao JY, Lu WH, Zhang JX,
Chen S, Chen ZY, Xiang YQ, Bao YN, Zheng FJ, et al: As an
independent unfavorable prognostic factor, IL-8 promotes metastasis
of nasopharyngeal carcinoma through induction of
epithelial-mesenchymal transition and activation of AKT signaling.
Carcinogenesis. 33:1302–1309. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Desai S, Laskar S and Pandey BN: Autocrine
IL-8 and VEGF mediate epithelial-mesenchymal transition and
invasiveness via p38/JNK-ATF-2 signalling in A549 lung cancer
cells. Cell Signal. 25:1780–1791. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fu XT, Dai Z, Song K, Zhang ZJ, Zhou ZJ,
Zhou SL, Zhao YM, Xiao YS, Sun QM, Ding ZB, et al:
Macrophage-secreted IL-8 induces epithelial-mesenchymal transition
in hepatocellular carcinoma cells by activating the
JAK2/STAT3/Snail pathway. Int J Oncol. 46:587–596. 2015.
|
|
15
|
Yu J, Ren X, Chen Y, Liu P, Wei X, Li H,
Ying G, Chen K, Winkler H and Hao X: Dysfunctional activation of
neurotensin/IL-8 pathway in hepatocellular carcinoma is associated
with increased inflammatory response in microenvironment, more
epithelial mesenchymal transition in cancer and worse prognosis in
patients. PLoS One. 8:e560692013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bauerle KT, Schweppe RE, Lund G, Kotnis G,
Deep G, Agarwal R, Pozdeyev N, Wood WM and Haugen BR: Nuclear
factor κB-dependent regulation of angiogenesis, and metastasis in
an in vivo model of thyroid cancer is associated with secreted
interleukin-8. J Clin Endocrinol Metab. 99:E1436–E1444. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Birchmeier W and Behrens J: Cadherin
expression in carcinomas: Role in the formation of cell junctions
and the prevention of invasiveness. Biochim Biophys Acta.
1198:11–26. 1994.PubMed/NCBI
|
|
18
|
Georgolios A, Batistatou A, Manolopoulos L
and Charalabopoulos K: Role and expression patterns of E-cadherin
in head and neck squamous cell carcinoma (HNSCC). J Exp Clin Cancer
Res. 25:5–14. 2006.PubMed/NCBI
|
|
19
|
Zhao Z, Ge J, Sun Y, Tian L, Lu J, Liu M
and Zhao Y: Is E-cadherin immunoexpression a prognostic factor for
head and neck squamous cell carcinoma (HNSCC)? A systematic review
and meta-analysis. Oral Oncol. 48:761–767. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jin B and Robertson KD: DNA
methyltransferases, DNA damage repair, and cancer. Adv Exp Med
Biol. 754:3–29. 2013. View Article : Google Scholar :
|
|
21
|
Marsit CJ, Posner MR, McClean MD and
Kelsey KT: Hypermethylation of E-cadherin is an independent
predictor of improved survival in head and neck squamous cell
carcinoma. Cancer. 113:1566–1571. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shargh SA, Sakizli M, Khalaj V, Movafagh
A, Yazdi H, Hagigatjou E, Sayad A, Mansouri N, Mortazavi-Tabatabaei
SA and Khorram Khorshid HR: Downregulation of E-cadherin expression
in breast cancer by promoter hypermethylation and its relation with
progression and prognosis of tumor. Med Oncol. 31:2502014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang G, Hu X, Lu C, Su C, Luo S and Luo
ZW: Promoter-hypermethylation associated defective expression of
E-cadherin in primary non-small cell lung cancer. Lung Cancer.
62:162–172. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li G, Liu Y, Yin H, Zhang X, Mo X, Tang J
and Chen W: E-cadherin gene promoter hypermethylation may
contribute to the risk of bladder cancer among Asian populations.
Gene. 534:48–53. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jin B, Ernst J, Tiedemann RL, Xu H,
Sureshchandra S, Kellis M, Dalton S, Liu C, Choi JH and Robertson
KD: Linking DNA methyltransferases to epigenetic marks and
nucleosome structure genome-wide in human tumor cells. Cell Rep.
2:1411–1424. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Estève PO, Chang Y, Samaranayake M,
Upadhyay AK, Horton JR, Feehery GR, Cheng X and Pradhan S: A
methylation and phosphorylation switch between an adjacent lysine
and serine determines human DNMT1 stability. Nat Struct Mol Biol.
18:42–48. 2011. View Article : Google Scholar :
|
|
27
|
Hodge DR, Cho E, Copeland TD, Guszczynski
T, Yang E, Seth AK and Farrar WL: IL-6 enhances the nuclear
translocation of DNA cytosine-5-methyltransferase 1 (DNMT1) via
phosphorylation of the nuclear localization sequence by the AKT
kinase. Cancer Genomics Proteomics. 4:387–398. 2007.
|
|
28
|
Shao N, Lu Z, Zhang Y, Wang M, Li W, Hu Z,
Wang S and Lin Y: Interleukin-8 upregulates integrin β3 expression
and promotes estrogen receptor-negative breast cancer cell invasion
by activating the PI3K/Akt/NF-κB pathway. Cancer Lett. 364:165–172.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bi LK, Zhou N, Liu C, Lu FD, Lin TX, Xuan
XJ, Jiang C, Han JL, Huang H, Zhang CX, et al: Kidney cancer cells
secrete IL-8 to activate Akt and promote migration of mesenchymal
stem cells. Urol Oncol. 32:607–612. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang L, Tang C, Cao H, Li K, Pang X, Zhong
L, Dang W, Tang H, Huang Y, Wei L, et al: Activation of IL-8 via
PI3K/Akt-dependent pathway is involved in leptin-mediated
epithelial-mesenchymal transition in human breast cancer cells.
Cancer Biol Ther. 16:1220–1230. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qian CN, Berghuis B, Tsarfaty G, Bruch M,
Kort EJ, Ditlev J, Tsarfaty I, Hudson E, Jackson DG, Petillo D, et
al: Preparing the ‘soil’: The primary tumor induces vasculature
reorganization in the sentinel lymph node before the arrival of
metastatic cancer cells. Cancer Res. 66:10365–10376. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li MQ, Luo XZ, Meng YH, Mei J, Zhu XY, Jin
LP and Li DJ: CXCL8 enhances proliferation and growth and reduces
apoptosis in endometrial stromal cells in an autocrine manner via a
CXCR1-triggered PTEN/AKT signal pathway. Hum Reprod. 27:2107–2116.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Di Croce L and Pelicci PG:
Tumour-associated hypermethylation: Silencing E-cadherin expression
enhances invasion and metastasis. Eur J Cancer. 39:413–414. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Palena C, Hamilton DH and Fernando RI:
Influence of IL-8 on the epithelial-mesenchymal transition and the
tumor microenvironment. Future Oncol. 8:713–722. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Feinberg A: DNA methylation in cancer:
Three decades of discovery. Genome Med. 6:362014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schraufstatter IU, Chung J and Burger M:
IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac
signaling pathways. Am J Physiol Lung Cell Mol Physiol.
280:L1094–L1103. 2001.PubMed/NCBI
|
|
38
|
Lane HC, Anand AR and Ganju RK: Cbl and
Akt regulate CXCL8-induced and CXCR1- and CXCR2-mediated
chemotaxis. Int Immunol. 18:1315–1325. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ochiai A: Dysfunction of cadherin cell
adhesion system in cancer invasion and metastasis. Gan To Kagaku
Ryoho. 26:565–571. 1999.In Japanese. PubMed/NCBI
|
|
40
|
Zheng Z, Pan J, Chu B, Wong YC, Cheung AL
and Tsao SW: Downregulation and abnormal expression of E-cadherin
and beta-catenin in nasopharyngeal carcinoma: Close association
with advanced disease stage and lymph node metastasis. Hum Pathol.
30:458–466. 1999. View Article : Google Scholar : PubMed/NCBI
|
